Altos Radar develops high-performance 4D Imaging Radar technology for driver-assisted and fully autonomous driving systems. This technology enhances vehicle perception and situational awareness, addressing the need for reliable and accurate environmental sensing in complex driving scenarios.

Hesai Technology designs and manufactures high-performance lidar sensors for autonomous vehicles and robotics, providing ultra-high resolution and long-range detection capabilities. Their technology enhances safety and navigation in advanced driver-assistance systems (ADAS) by accurately mapping the environment, addressing the need for reliable perception in self-driving applications.

Manus is an AI‑powered platform that lets teams generate and edit designs, slides, images, music, and code, and automate complex workflows such as research, data extraction, and deployment—all within a single web app. It provides an interactive canvas, multimodal generation, autonomous agents that can browse and execute tasks, and integrates with tools like Slack, Google Workspace, and GitHub, enabling rapid production of creative and operational assets without separate applications.

Meliora Therapeutics focuses on advancing oncology drug development for the 21st century. The company is dedicated to creating novel therapeutic solutions to address unmet needs in cancer treatment. Their work centers on bringing forward new pharmaceutical agents through rigorous development pipelines.

Momenta develops autonomous driving technology that utilizes a data-driven approach and iterative algorithms to deliver mass-production-ready solutions, including Mpilot and MSD, which support features from Level 2 to Level 2++. Their scalable robotaxi service enhances urban mobility by providing safe and efficient transportation in complex environments.

Moonshot AI offers Kimi, a 1‑trillion‑parameter mixture‑of‑experts language model that supports up to 256 k token context and multimodal inputs (text, image, audio). The platform provides real‑time web search, code execution, and file‑based Q&A through a unified API, enabling developers to embed extended‑context, reasoning, and tool‑oriented capabilities with usage‑based billing. Services are cloud‑hosted with enterprise‑grade security and monitoring.

Moonshot AI develops Kimi, an intelligent assistant capable of processing extensive text and accessing online information, enhancing user interaction through advanced natural language processing. The platform offers a flexible API for seamless integration, enabling developers to create applications that leverage Kimi's capabilities for improved user engagement and efficiency.

Redesign Science utilizes its NUVO™ technology platform, which combines physics-based molecular dynamics and generative AI, to develop first-in-class small molecule Targeted Protein Interaction Modulators (TPIM™). The company targets the structural protein interactome to enhance control over cellular biology, addressing the complexities of early-stage drug discovery.

Tagomi is a cryptocurrency trading platform that utilizes a smart order router to connect users with major exchanges, facilitating efficient execution of trading strategies. It offers institutional-grade financing solutions, including lending and margin trading, to enhance capital efficiency and optimize returns in volatile markets.

Xellarbio integrates machine learning and AI with large-scale wet-lab experiments to address complexity in drug discovery. The company utilizes pharma-scale organ-on-a-chip technology combined with image-based AI for pre-clinical testing. This approach aims to accelerate the development pipeline by better modeling human biology.

XtalPi is a pharmaceutical technology company that utilizes computational modeling and machine learning to predict drug interactions and properties, followed by experimental validation in wet labs. This approach reduces the time and cost associated with traditional drug discovery processes, enabling faster development of effective therapeutics.